Teva Pharmaceutical Industries Ltd ADR buy Subdi
Summary
This prediction ended on 24.01.12 with a price of €35.30. With a performance of 6.69%, the BUY prediction by Subdi for Teva Pharmaceutical Industries Ltd ADR closed with a slight gain. Subdi has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -2.065% | -2.065% | 86.099% | 108.020% |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
Comments by Subdi for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Update 04.11.2011- Nachkauf
Überzeugende Argumente für Teva von SA-Autor Bret Jensen:
5 reasons TEVA is a strong buy at $39 a share:
- TEVA is selling at the bottom of its five-year valuation range based on P/E, P/S, P/B, P/CF.
- In addition to the exclusive launch of the Zyprexa generic version, Teva should have Bio-T-Gel approved by the FDA in the fourth quarter.
- TEVA is trying to put in a technical base just under $38 over the last three months (see chart - click to enlarge)
- TEVA has an A- rated balance sheet, is selling at 8 times cash flow, has a projected five-year PEG of less than .9 and a forward PE of less than 7. It also yields almost 2%.
- The stock is still selling under analysts’ price targets. The median analysts’ price target on Teva Pharmaceuticals is $58 and S&P has a price target of $54 on TEVA
Ursprünglicher Text vom 24.07.2011 :
Wenn selbst Bloomberg sagt, dass Teva steigt,...
...dann muss es wohl stimmen.
Bloomberg ist so ein Zwischending aus Nachrichtenagentur und Marktforschungsinstitut, und sie legen großen Wert darauf, weniger Falschmeldungen als alle anderen zu erzeugen. Wenn die so einen Beitrag wie diesen hier veröffentlichen, dann hat das nach meiner Erfahrung schon Substanz, und ist nicht nur eine Meinung von vielen.
Dass Teva total unterbewertet war, war schon lange klar, aber wann sie endlich steigt, ist mir erst heute klar geworden:
Bald!
Stopped prediction by Subdi for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
15.05.19
28.05.19
28.05.19
Teva Pharmaceutical Industries Ltd ADR
14.05.19
15.05.19
15.05.19